Ukrainian Journal Health of Woman. 2023. 2(165): 35-39; doi 10.15574/HW.2023.165.35
Rynda-Dziuryi N. A., Govsieiev D. O.
Bogomolets National Medical University, Kyiv, Ukraine

For citation: Rynda-Dziuryi NA, Govsieiev DO. (2023). Key mechanisms underlying miscarriage, literature review. Ukrainian Journal Health of Woman. 2(165): 35-39. doi: 10.15574/HW.2023.165.35.
Article received: Jan 25, 2023. Accepted for publication: Apr 18, 2023.

Pregnancy is a special natural state of a woman’s body, in which important and extremely complex physiological processes take place, which play a great role in the existence and restoration of the population. Miscarriage, or involuntary termination of pregnancy, is one of the most important problems in the field of health care both in Ukraine and throughout the world as a whole. Modern obstetric strategy aimed at reducing perinatal morbidity, mortality of women and disability of children, however, numerous studies and data from leading clinics indicate the absence of a tendency to reduce reproductive losses.
Purpose – to analyze and summarize the literature on the key mechanisms underlying miscarriage; to discuss new concepts in this area.
Used analytical and bibliosemantic methods, review and analysis of modern domestic and foreign literature.
Given the high trend of «ageing motherhood», contradictory data on the cause and effect relationship among many known causes of miscarriage, the lack of consensus among experts on methods of diagnosis, monitoring and treatment of pregnant women with habitual miscarriage, as well as negative lifestyle factors, the introduction of new algorithms for diagnostic and preventive measures for women remains relevant.
No conflict of interests was declared by the authors.
Keywords: miscarriage, first trimester of pregnancy, habitual miscarriage, hyperandrogenic disorders, Hsp60.

REFERENCES

1. Adu-Gyamfi EA, Wang YX, Ding YB. (2020, Feb 12). The interplay between thyroid hormones and the placenta: a comprehensive review. Biol Reprod. 102 (1): 8-17. doi: 10.1093/biolre/ioz182. PMID: 31494673. https://doi.org/10.1093/biolre/ioz182; PMid:31494673

2. Blue NR, Page JM, Silver RM. (2019). Genetic abnormalities and pregnancy loss. Semin Perinatol. 43: 66-73. https://doi.org/10.1053/j.semperi.2018.12.002; PMid:30638594 PMCid:PMC8272960

3. Cappello F, Gammazza A, Piccionello A et al. (2014). Hsp60 chaperonopathies and chaperonotherapy: targets and agents. Expert Opin. Ther. Targets. 18; 2: 185-208. https://doi.org/10.1517/14728222.2014.856417; PMid:24286280

4. Coomarasamy A, Devall AJ, Brosens JJ, Quenby S, Stephenson MD, Sierra S et al. (2020, Aug). Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 223 (2): 167-176. Epub 2020 Jan 31. https://doi.org/10.1016/j.ajog.2019.12.006; PMid:32008730 PMCid:PMC7408486

5. Garcia D, Erkan D. (2018). Diagnosis and Management of the Antiphospholipid Syndrome. N Engl J Med. 378: 2010-2021. https://doi.org/10.1056/NEJMra1705454; PMid:29791828

6. Kacprzak M, Chrzanowska M, Skoczylas B et al. (2016). Genetic causes of recurrent miscarriages. Ginekol Pol. 87: 722-726. https://doi.org/10.5603/GP.2016.0075; PMid:27958626

7. Kaczprzak M, Chrzanowska M, Skochilas B, Moczulska A, Borowiec M, Sieroszewski P. (2016). Genetic causes of repeated miscarriages. Ginekol Pol. 87 (10): 722-726. https://doi.org/10.5603/GP.2016.0075; PMid:27958626

8. Khomami MB, Joham AE, Boyle JA, Piltonen T, Silagi M, Arora C et al. (2019, Jan 23). Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity – a systematic review, meta-analysis and meta-regression. Obesity Reviews. 20 (5): 659-674. https://doi.org/10.1111/obr.12829; PMid:30674081

9. Matsuda M, Sasaki A, Shimizu K, Kamada Y, Noguchi S, Hiramatsu Y, Nakatsuka M. (2017, Jun). Increased Anti-HSP60 and Anti-HSP70 Antibodies in Women with Unexplained Recurrent Pregnancy Loss. Acta Med Okayama. 71 (3): 201-208. doi: 10.18926/AMO/55202. PMID: 28655939.

10. Mukhammedaminova DT, Nasyrova KK. (2022, Jul 08). Habitual Miscarriage of Pregnancy with Endocrine Disorders. Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan.

11. Nepyivoda OM, Ryvak TB. (2020, May). Threatened miscarriage and pregnancy loss: contemporary aspects of the problem. Wiadomości Lekarskie. LXXIII; 5. https://doi.org/10.36740/WLek202005134; PMid:32386388

12. Oshurkevych OE, Oshurkevych OO. (2017). Miscarriage: causes, diagnosis, treatment. Medical forum Scientific journal. 11 (11): 76. URL: http://www.medicinelviv.org.ua/archive/2017/11_2017.pdf#page=76.

13. Poletaev AB, Morozov SG. (2000). Changes of maternal serum natural antibodies of IgG class to proteins МBP, S100, ACBP14/18 and MP65 and embryonic misdevelopments in humans. Human Antibody. 9: 216-222. https://doi.org/10.3233/HAB-2000-9404; PMid:11341175

14. Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J et al. (2021, May 1). Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 97 (10285): 1658-1667. Epub 2021 Apr 27. https://doi.org/10.1016/S0140-6736(21)00682-6; PMid:33915094

15. Rahman TU, Ullah K, Guo MX, Pan HT, Liu J, Ren J et al. (2018, May 15). Androgen-induced alterations in endometrial proteins crucial in recurrent miscarriages. Oncotarget. 9 (37): 24627-24641. https://doi.org/10.18632/oncotarget.24821; PMid:29872493 PMCid:PMC5973874

16. Salmon JE, Mineo C, Giles I et al. (2017). Mechanisms of Antiphospholipid Antibody-Mediated Pregnancy Morbidity. In: Antiphospholipid Syndrome. Springer International Publishing: 117-143. https://doi.org/10.1007/978-3-319-55442-6_6

17. Silva M, de Leeuw N, Mann K et al. (2019). European guidelines for constitutional cytogenomic analysis. Eur J Hum Genet. 27: 1-16. https://doi.org/10.1038/s41431-018-0244-x; PMid:30275486 PMCid:PMC6303289

18. Sugiura-Ogasawara M, Ozaki Y, Suzumori N. (2014). Management of recurrent miscarriage. J Obstet Gynaecol Res. 40: 1174-1179. https://doi.org/10.1111/jog.12388; PMid:24754846

19. Sun YF, Zhang J, Xu YM, Cao ZY, Wang YZ, Hao GM, Gao BL. (2020, Dec 3). High BMI and Insulin Resistance Are Risk Factors for Spontaneous Abortion in Patients With Polycystic Ovary Syndrome Undergoing Assisted Reproductive Treatment: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 11: 592495. https://doi.org/10.3389/fendo.2020.592495; PMid:33343510 PMCid:PMC7744738

20. The Practice Committee of the American Society for Reproductive Medicine. (2012). Evaluation and treatment of recurrent pregnancy loss: A committee opinion. Fertil Steril. 98 (5): 1103-1111. https://doi.org/10.1016/j.fertnstert.2012.06.048; PMid:22835448

21. Toth B, Würfel W, Bolmann M, Zshoke J, Rudnik-Schöneborn S, Navrot F et al. (2018, Apr). Recurrent miscarriage: diagnostic and therapeutic procedures. Guide DGGG, OEGGG and SGGG (level S2k, registration number AWMF 015/050). Geburtshilfe Frauenheilkd. 78 (4): 364-381. Epub 2018 Apr 27. https://doi.org/10.1055/a-0586-4568; PMid:29720743 PMCid:PMC5925690

22. Trofimovich OV, Borisyuk OYu, Chubei GV. (2021). Rannia vtrata vahitnosti: suchasnyi stan problemy. Kyiv. URL: https://health-ua.com/article/66390-rannya-vtrata-vagtnost-suchasnij-stan-problemi.